Strategic Wealth Partners’s Avanos Medical AVNS Stock Holding History

Strategic Wealth Partners’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$746	Hold	30	–	–	﹤0.01%	1304
2026 Q1	$420	Hold	30	–	–	﹤0.01%	1334
2025 Q4	$337	Buy	30 +29	+2,900%	+$332	﹤0.01%	1362
2025 Q3	$12	Hold	1	–	–	﹤0.01%	1307
2025 Q2	$12	Buy	+1	New	+$13	﹤0.01%	1138
2019 Q3	–	Sell	-24	Closed	-$1K	–	725
2019 Q2	$1K	Buy	+24	New	+$1.03K	﹤0.01%	710
2018 Q3	–	Sell	-20	Closed	-$181K	–	637
2018 Q2	$181K	Hold	20	–	–	0.1%	147
2018 Q1	$1K	Hold	20	–	–	﹤0.01%	764
2017 Q4	$1K	Buy	+20	New	+$919	﹤0.01%	720

Other funds holding AVNS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TAL

TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Strategic Wealth Partners's AVNS Position: Q2 2026 in Review

Strategic Wealth Partners held its Avanos Medical (AVNS) position steady in Q2 2026 at 30 shares worth $746. The position accounts for ﹤0.01% of the portfolio, ranked #1304.

Strategic Wealth Partners first reported a position in AVNS in Q4 2017 and has held it in 9 quarters since. The position peaked at $181K in Q2 2018. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

Strategic Wealth Partners held 30 shares of Avanos Medical worth $746 as of Q2 2026.
Strategic Wealth Partners left its Avanos Medical share count unchanged in Q2 2026.
Avanos Medical made up ﹤0.01% of Strategic Wealth Partners's portfolio in Q2 2026, its #1304 holding.
Strategic Wealth Partners first reported a position in Avanos Medical in Q4 2017 and has held it in 9 quarters since.
Strategic Wealth Partners's Avanos Medical position peaked at $181K in Q2 2018.
286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Strategic Wealth Partners's 13F filing for Q2 2026, filed 12 Aug 2026.